Merck Has Completed Manufacturing of 10 Million Courses of Therapy and Remains on Track to Produce at Least 20 Million Courses in 2022 to Provide Widespread Access to Molnupiravir Globally… Read More
British Columbia is proving once again that it is a leading global hub for biotech innovation. Gandeeva Therapeutics, a Vancouver-based company led by UBC Faculty of Medicine professor Dr. Sriram… Read More
Post-operative infections occur in up to 300,000 patients per year in the United States and cost the US healthcare system tens of billions of dollars a year.[i] Ondine Biomedical Inc…. Read More
VANCOUVER, B.C. — Algernon Pharmaceuticals Inc. (the “Company” or “Algernon”) (CSE: AGN) (FRANKFURT: AGWO) (OTCQB: AGNPF) a clinical stage pharmaceutical development company, is pleased to announce that it has completed… Read More
Enjaymo is the only approved treatment to decrease the need for red blood cell transfusion due to hemolysis, the destruction of red blood cells, in adults with cold agglutinin disease… Read More
